Patent Opposition Database

Join our community to challenge unmerited drug patents

  1. Home
  2. Drugs
  3. Osimertinib
  4. Cilfa Opposition, Osimertinib, (Ar115019 A2)

Cilfa Opposition, Osimertinib, (Ar115019 A2)

Download Pdf Subscribe to updates

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number)
AR115019A2
Who filed
CILFA
Country
Argentina
Opposition type
Pre-Grant
Opposition status
Under Examination
Date
04-01-2021
Patent type
Polymorphs
No Annotations

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

Be as descriptive as necessary

Cancel

10 similar patent oppositions